Cargando…
An Evaluation of Levalbuterol HFA in the Prevention of Exercise-Induced Bronchospasm
BACKGROUND: Exercise-induced bronchospasm (EIB) affects up to 90% of all patients with asthma. OBJECTIVE: This study evaluated the ability of levalbuterol hydrofluoroalkane (HFA) 90 μg (two actuations of 45 μg) administered via metered dose inhaler (MDI) to protect against EIB in mild-to-moderate as...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Informa Healthcare
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409177/ https://www.ncbi.nlm.nih.gov/pubmed/17994402 http://dx.doi.org/10.1080/02770900701595667 |